← Back to FLNA

Filana Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSMar 2026Filed 07/05/2026Sep 2025Filed 12/11/2025Jun 2025Filed 12/11/2025Mar 2025Filed 07/05/2026Sep 2024Filed 12/11/2025Jun 2024Filed 12/11/2025Mar 2024Filed 12/11/2025Sep 2023Filed 07/11/2024
−$10−$11−$44−$23−$28$6.2$25−$26
−$0.21−$0.22−$0.92−$0.48−$0.58$0.13−$0.43−$0.61
48484848464442

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.